Evaluating NICE guidelines in regards to cannabis-based medicinal products targeting pain
Campaigners argue the new regulations are not extensive enough where the recommendation of cannabis-based medicine for pain is concerned.
By
GlobalData
All Articles
IDWeek 2019: Long-acting antiretroviral therapy shows promise for HIV patients with low adherence
HIV infections can be well controlled with antiretroviral therapy to a degree where the viral load is not detectable…
By
Global Blood Therapeutics leads in world sickle cell disease trials
Sickle cell disease comprises a group of inherited disorders caused by mutations of haemoglobin subunit beta.
By
Trends in clinical trials for gene therapies in neurology
84% of gene therapy trials happening in various neurology indications, listed in GlobalData’s Pharma Intelligence Center, are in early-stage…
By
Top ten drugs in biosimilar trials globally
The number one drug in biosimilar clinical trials by count is adalimumab biosimilar, referencing the branded biologic Humira.
By
Governments are playing a bigger role in cell and gene therapy manufacturing
Currently, the UK accounts for 16% of global cell therapy manufacturing facilities, according to GlobalData’s Contract Service Provider Database.
By